首页> 外文期刊>International Journal of Pharmaceutics >High-throughput in vitro drug release and pharmacokinetic simulation as a tool for drug delivery system development: Application to intravitreal ocular administration
【24h】

High-throughput in vitro drug release and pharmacokinetic simulation as a tool for drug delivery system development: Application to intravitreal ocular administration

机译:高通量的体外药物释放和药代动力学模拟作为药物递送系统开发的工具:在玻璃体内施用中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

In vitro estimation of release kinetics from drug delivery systems is needed in formulation development. Cost-effective methods of assessment for delivery systems are needed particularly in the case of biologicals and drug administration routes that are difficult to screen in vivo (e. g. intraocular drug delivery). As a proof-of-concept, we demonstrate here a practical high-throughput methodology to investigate in vitro drug release and predict resulting drug concentrations in the eye after intravitreal administration. 96-well plate based assay aided with robotic sampling was used to study release of eight model drugs of varying physicochemical properties (dexamethasone, vancomycin, alpha-lactalbumin, lysozyme, myoglobin, albumin, lactoferrin, human IgG) from twelve alginate microsphere formulations. The amount of drug released over a period of time was assessed by photometric and fluorescence methods. In vitro drug release rates obtained were used in pharmacokinetic simulations using one-compartment model of the vitreal cavity with anatomical volume of distribution and clearance estimates based on the literature precedence. An integrated approach of drug release screening and pharmacokinetic simulations can prove to be a useful methodology in guiding formulation development for ocular delivery in animal models. In general, the methodology has the potential to be a cost-effective tool for early stage drug delivery system discovery and development. (C) 2014 Elsevier B.V. All rights reserved.
机译:在制剂发育中需要从药物递送系统中进行释放动力学的体外估计。特别是在难以筛选体内筛选的生物学和药物管理途径的情况下,需要对递送系统进行成本效益的评估方法(例如,e .g。眼内药物递送)。作为概念验证,我们在此证明了一种实用的高通量方法,以研究体外药物释放和预测玻璃体术施用后眼中的药物浓度。基于孔板的基于孔板的测定辅助机器人取样来研究来自12次藻酸盐微球体制剂的八种不同的物理化学性质(地塞米松,万古霉素,α-乳白,溶菌酶,乳铁蛋白,人IgG)的八种模型药物。通过光度和荧光方法评估在一段时间内释放的药物量。使用塑料腔的单室模型使用的体外药物释放速率用于药代动力学模拟,基于文献优先级的分布和清除估计解剖学体积。药物释放筛选和药代动力学模拟的综合方法可以证明是引导动物模型中眼递送的制剂开发的有用方法。一般而言,该方法有可能成为早期药物交付系统发现和发展的成本效益的工具。 (c)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号